Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: Potential mechanisms for exacerbation of diabetic retinopathy by hypertension

Diabetes

Volumn 50, Issue 2, 2001, Pages 444-454

  Suzuma, Izumi ^a   Hata, Yasuaki ^a   Clermont, Allen ^a   Pokras, Frank ^a   Rook, Susan L ^a   Suzuma, Kiyoshi ^a   Feener, Edward P ^a   Aiello, Lloyd Paul ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN TYROSINE KINASE; RETINAL; THYMIDINE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE EXACERBATION; HYPERTENSION; HYPERTENSION RETINOPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR AFFINITY; RECEPTOR BLOCKING; SCATCHARD PLOT;

EID: 0035122468     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.2.444     Document Type: Article

References (101)

1. The Wisconsin Epidemiologic Study of Diabetic Retmopathy. XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes (see comments)
2. Systolic hypertension and duration of diabetes mellitus are important determinants of retinopathy and microalbuminuria in young diabetics
3. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: A 5-year follow-up study of 442 adult patients in routine care
4. Case-control study of the risk factors for age related macular degeneration. France-DMLA Study Group
5. Factors associated with age-related macular degeneration: An analysis of data from the first National Health and Nutrition Examination Survey
6. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study
7. Drusen in age-related macular degeneration: Pathogenesis, natural course, and laser photocoagulation induced regression
8. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration
9. Diabetic retinopathy (Technical Review)
10. Progression of diabetic retinopathy in pregnancy: Association with hypertension in pregnancy
11. Diabetic retinopathy in African Americans with type 1 diabetes: The New Jersey 725. II. Risk factors
12. Tight bloood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
13. Blood pressure and microvascular complications in type 1 (insulin dependent) diabetic patients without hypertension
14. Risk factors for diabetic retinopathy among Saudi diabetics
15. Diabetic macular edema: Risk factors and concomitants
16. Grid photocoagulation for diffuse macular edema
17. Diabetic macular edema
18. Pathophysiology of hypertensive retinopathy
19. Hypertensive retinopathy: Description, classification, and prognosis
20. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
21. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis
22. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis
23. Purification and NH2-terminal amino acid sequence of guinea pig minor-secreted vascular permeability factor
24. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
25. Angiogenic factors
26. Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
27. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels
28. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
29. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders (see comments)
30. Growth factors in age-related macular degeneration: Pathogenic and therapeutic implications
31. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy
32. Expression of vascular endothelial growth factor in experimental choroidal neovascularization
33. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor
34. Vascular endothelial growth factor upregulation in human central retinal vein occlusion
35. Hypoxic regulation of vascular endothelial growth factor in retinal cells
36. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
37. Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway
38. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells
39. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy
40. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
41. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
42. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
43. Pulsed Doppler: Diameter, blood flow velocity and volumic flow of the brachial artery in sustained essential hypertension
44. Quantitative analysis of retinal vascular changes in essential and renovascular hypertension
45. Nitric oxide synthase expression in endothelial cells exposed to mechanical forces
46. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy
47. Activation of PDGF receptor alpha in vascular smooth muscle cells by mechanical stress
48. Stretch activates heparin-binding EGF-like growth factor expression in bladder smooth muscle cells
49. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor
50. Activation of angiotensinogen gene in cardiac myocytes by angiotensin II and mechanical stretch
51. Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells
52. Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF
53. Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat
54. Stretch-induced VEGF expression in the heart
55. Pulsatile stretch stimulates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes
56. Mechanical stretch induces vascular permeability factor in human mesangial cells: Mechanisms of signal transduction
57. Induction of vascular endothelial growth factor after application of mechanical stress to retinal pigment epithelium of the rat in vitro
58. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta
59. A platelet factor stimulating the proliferation of vascular endothelial cells: Partial purification and characterization
60. Developmental expression and regulation of basic fibroblast growth factor and vascular endothelial growth factor in rat decidua and in a decidual cell line
61. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium
62. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
63. Homologons up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro
64. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
65. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
66. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells
67. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression
68. Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes
69. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway
70. Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial ceils
71. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells
72. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells
73. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells
74. Candesartan cilexetil an angiotensin II receptor blocker (Review)
75. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy- 1-[[2′ - (1H-tetrazol-5-yl) biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1- (cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-l-[[2′ - (1Htetrazol-5- yl)biplienyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV116)
76. Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes
77. Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist: Effects on smooth muscle cell migration and proliferation after balloon catheter injury
78. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat
79. Development of a strain of spontaneously hypertensive rats
80. Role of the renin-angiotensin system in post-transplantation hypertension in patients with multiple kidneys
81. TGF-beta receptor expression and binding in rat mesangial cells: Modulation by glucose and cyclic mechanical strain
82. A method of quantifying retinal microvascular alterations associated with blood pressure and age
83. The effect of experimental hypertension on retinal vascular autoregulation in humans: A mechanism for the progression of diabetic retinopathy
84. Pericytes in the microvasculature
85. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195
86. Regulation of glomerular volume in normal and partially nephrectomized rats
87. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells
88. Mechanical stretching increases the number of epithelial cells synthesizing DNA in culture
89. Mechanical stress stimulates aortic endothelial cells to proliferate
90. Complications associated with posterior staphyloma
91. Natural history of choroidal neovascularization in degenerative myopia
92. Pathologic myopia and choroidal neovascularization
93. Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization
94. Neovascular glaucoma: Etiologic considerations
95. Signal transducdon of mechanical stresses in the vascular wall
96. Cyclic strain stress-induced mitogen-activated protein kinase (MAPK) phosphatase 1 expression in vascular smooth muscle cells is regulated by Ras/Rac-MAPK pathways
97. Pulsatile stretch stimulates superoxide production and activates nuclear factor-kappa B in human coronary smooth muscle
98. Retinal vascular patterns. IV. Diabetic retinopathy
99. Relationship of microvascular disease in diabetes to metabolic control
100. Vasomotor responses in chronically hyperperfused and hypoperfused rat mesenteric arteries